| MolName | N-[4-[4-[(E)-[3-(4-acetamidophenyl)-5-oxo-1-phenylpyrazol-4-ylidene]methyl]-5-oxo-1-phenyl-4H-pyrazol-3-yl]phenyl]acetamide |
| MolecularFormula | C35H28N6O4 |
| Smiles | CC(Nc(cc1)ccc1C(C(/C=C(\C(c(cc1)ccc1NC(C)=O)=NN1c2ccccc2)/C1=O)C1=O)=NN1c1ccccc1)=O |
| InChI | InChI=1S/C35H28N6O4/c1-22(42)36-26-17-13-24(14-18-26)32-30(34(44)40(38-32)28-9-5-3-6-10-28)21-31-33(25-15-19-27(20-16-25)37-23(2)43)39-41(35(31)45)29-11-7-4-8-12-29/h3-21,30H,1-2H3,(H,36,42)(H,37,43)/t30-/m0/s1 |
| InChIK | GWGNTTBSFNSUDQ-PMERELPUSA-N |
| TotalMolweight | 596.645 |
| Molweight | 596.645 |
| MonoisotopicMass | 596.217204 |
| CLogP | 5.4095 |
| CLogS | -6.9 |
| H Acceptors | 10 |
| H Donors | 2 |
| TotalSurfaceArea | 447.73 |
| Relative PSA | 0.23496 |
| PolarSurfaceArea | 123.54 |
| Druglikeness | 4.9731 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.42222 |
| Fragments | 1 |
| Non HAtoms | 45 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 3 |
| Symmetricatoms | 8 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - N-[4-[4-[(E)-[3-(4-acetamidophenyl)-5-oxo-1-phenylpyrazol-4-ylidene]methyl]-5-oxo-1-phenyl-4H-pyrazol-3-yl]phenyl]acetamide | 2 - N-[4-[4-[(E)-[3-(4-acetamidophenyl)-5-oxo-1-phenylpyrazol-4-ylidene]methyl]-5-oxo-1-phenyl-4H-pyrazol-3-yl]phenyl]acetamide